Search results for "Infectious diseases"
Experts discuss the data on post-COVID-19 symptoms
ACP and Annals of Internal Medicine's ninth COVID-19 forum addressing postacute sequelae of COVID-19 (PASC) offered a better understanding of persistent symptoms after SARS-CoV-2 infection.
https://immattersacp.org/archives/2022/07/experts-discuss-the-data-on-post-covid-19-symptoms.htm
1 Jul 2022
Nirmatrelvir/ritonavir rarely leads to rebound, doesn't help average-risk patients, studies find
A retrospective analysis found that symptom rebound occurred in less than 1% of high-risk COVID-19 patients treated with nirmatrelvir/ritonavir, while the manufacturer reported that the drug didn't show significant benefit in average-risk patients.
https://immattersacp.org/weekly/archives/2022/06/21/2.htm
21 Jun 2022
ACP, Annals of Internal Medicine host ninth forum on COVID-19
A full recording of COVID-19 Forum IX: Management of Patients with Persistent Symptoms after COVID-19 is available for replay online.
https://immattersacp.org/weekly/archives/2022/05/31/4.htm
31 May 2022
IDSA offers guidance on managing drug interactions with nirmatrelvir/ritonavir
The Infectious Diseases Society of America (IDSA) listed six steps to help clinicians prescribe the COVID-19 medication while minimizing interaction risks. Other recent research looked at neuropsychiatric conditions after COVID-19 and hospital profits during the pandemic.
https://immattersacp.org/weekly/archives/2022/05/17/2.htm
17 May 2022
Register now for ACP and Annals of Internal Medicine's COVID-19 Forum IX: Management of Patients with Persistent Symptoms after COVID-19
During the May 24 virtual live event, a panel of experts will discuss challenges related to the care of patients who have lasting symptoms following acute SARS-CoV-2 infection.
https://immattersacp.org/weekly/archives/2022/05/17/3.htm
17 May 2022
Inclusivity that never dies: The future of ACP
ACP's President recaps his tenure as he discusses the College's efforts at diversity, equity, and inclusion.
https://immattersacp.org/archives/2022/04/inclusivity-that-never-dies-the-future-of-acp.htm
1 Apr 2022
Two studies show effectiveness of mRNA boosters against omicron variant
Other recent research on COVID-19 revealed the high transmissibility of the omicron stealth variant and changes in the brain after SARS-CoV-2 infection.
https://immattersacp.org/weekly/archives/2022/03/15/5.htm
15 Mar 2022
New data on COVID-19 vaccines' effectiveness against omicron, among immunocompromised
One English analysis showed how COVID-19 boosters increase protection against symptomatic infection from omicron, while two studies looked at vaccinating the immunocompromised, and ACP videos worked to educate patients and increase vaccine uptake.
https://immattersacp.org/weekly/archives/2022/03/08/2.htm
8 Mar 2022
When to test, isolate, prescribe for outpatient COVID-19
Panelists at ACP and Annals of Internal Medicine's eighth virtual forum on COVID-19 discussed the latest recommendations and treatment options.
https://immattersacp.org/archives/2022/03/when-to-test-isolate-prescribe-for-outpatient-covid-19.htm
1 Mar 2022
New research on PASC, COVID-19 infection and vaccination during pregnancy
Two studies analyzed postacute sequelae of COVID-19 (PASC) in older and ICU patients. Other new research showed that symptomatic infection during delivery raised risks in pregnant women but vaccination during pregnancy was safe. An ACP/Annals of Internal Medicine forum focused on outpatient management of COVID-19, and the FDA issued an emergency use authorization for a new monoclonal antibody treatment.
https://immattersacp.org/weekly/archives/2022/02/15/1.htm
15 Feb 2022